contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-1212-2025-flugger-wirtek-og-bioporto

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Analyst

Philip Coombes

Flügger develops, produces, markets, and sells interior and exterior decorative paint, wood stains, filler, and tools; selling to professional painters, private customers, and builder’s merchants. Flügger originates from Denmark and is listed on the Nasdaq OMX Copenhagen Stock Exchange.

Flügger has a strong market position in the Nordic markets, where it is the market leader in Denmark. Its physical Flügger Farver stores are well known throughout the Nordic region and are the company’s primary sales channel; however, Flügger also has private label sales via builder’s merchants as well as developing e-commerce capabilities.

Flügger’s position in the Nordics is relatively stable, whereas the company has growth via export markets and its own presence in Eastern Europe, with a long history in Poland and by the acquisitions of Unicell and Eskaro.

Flügger Group

WirTek is an IT company. The company is focused on developing software and hardware solutions that affect web, mobile and integrated complete systems. Operations are held on a global level, with the largest presence in the Nordic region and Europe, where customers mainly consist of small and medium-sized business customers. WirTek was founded in 2001 and is headquartered in Aalborg.

Wirtek

BioPorto is a Danish in-vitro diagnostics company with headquarters in Copenhagen, Denmark. The company was founded in 2000. BioPorto has one marketed product, the NGAL test, for early diagnosis of acute kidney injury (AKI), which is commercially available in Europe, Canada, Asia, and Israel.

It has received breakthrough designation from the FDA for AKI in the pediatric indication, for which it is currently conducting data analysis following the completion of enrollment of patients for its Phase 3 study which will lead to an expected application to FDA. Future plans include further FDA submission for adult indication as well as other markets. 

BioPorto

Dagens aktienyheder med Flügger, Wirtek og BioPorto

Fl&#xfc;gger offentligg&#xf8;r sine Q2 2025/26-resultater senere i formiddagen. Vores seneste estimater for H1 2025/26e indikerer en oms&#xe6;tning p&#xe5; MDKK 1.294, svarende til omkring 4 % &#xe5;/&#xe5;-v&#xe6;kst, samt et justeret EBIT p&#xe5; MDKK 156, hvilket svarer til en EBIT-margin p&#xe5; ca. 12,1 % (mod MDKK 140 og en margin p&#xe5; 11 % i H1 2024/25). Forud for offentligg&#xf8;relsen forventer vi, at stabil udvikling i Danmark opvejes af st&#xe6;rk fremgang i Sverige og fortsat tocifret v&#xe6;kst i Polen. Gunstige valutaeffekter samt et positivt produktskifte mod Fl&#xfc;ggers egne h&#xf8;jmarginprodukter og det h&#xf8;jmarginerede polske marked forventes at underst&#xf8;tte den fortsatte marginudvidelse. Link til opslag: <a href="https://www.inderes.dk/analyst-comments/flugger-q22526-preview-gradual-growth-and-margin-expansion-to-continue-with-positive-fx-impacts">https://www.inderes.dk/analyst-comments/flugger-q22526-preview-gradual-growth-and-margin-expansion-to-continue-with-positive-fx-impacts</a>
Wirtek kunne i g&#xe5;r annoncere, at bestyrelsesformanden igennem et kontrolleret selskab af ham, har erhvervet 57.000 aktier og har &#xf8;get sin totale ejerandel til 10,33 % af selskabets aktiekapital. Dette kommer efter, at selskabet har i forbindelse med 3 kvartal regnskabet har fremlagt en ny strategiplan, med udmeldinger om at tilbagevenden til v&#xe6;kst i 2026.
Bioporto kunne i g&#xe5;r efter markedsluk annoncere, at Niels H&#xf8;y Nielsen har valgt at fratr&#xe6;de sin stilling som CFO i BioPorto for at tiltr&#xe6;de en stilling som CFO i et andet selskab. Niels H&#xf8;y Nielsen forts&#xe6;tter i sin nuv&#xe6;rende rolle frem til marts 2026, hvor selskabet i mellemtiden vil vurdere den fremtidige organisationsstruktur.
&#xa0;Disclaimer:&#xa0;<a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:54143576" data-guid="17" data-object-urn="urn:li:organization:54143576" data-original-text="HC Andersen Capital" data-test-ql-mention="true">HC Andersen Capital</a> modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale.&#xa0; /Philip Coombes d. 12/12-2025 kl. 08:46.

Dagens aktienyheder 12/12-2025: Flügger, Wirtek og BioPorto

Stay up to date